BIOMAT Database Logo BIOMAT Database Logo

Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents. 2014

Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, Uttar pradesh 226031, India. Electronic address: sashidhar123@gmail.com.

A series of novel indole-chalcone fibrates were synthesized and their hypolipidemic activity was evaluated in triton WR-1339 induced hyperlipidemic rat model. Preliminary studies indicated that the hybrids 19, 24 and 29 exhibited potent in vitro antioxidant and significant in vivo antidyslipidemic effects. Our results suggest that these new hybrid architectures may serve as promising leads for the development of next generation lipid lowering agents.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Coumarin chalcone fibrates: a new structural class of lipid lowering agents.
June 2013, European journal of medicinal chemistry,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Design, synthesis, and biological activity of 9-O-cinnamoylberberines as novel lipid-lowering agents.
January 2023, Natural product research,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Synthesis of novel benzocoumarin derivatives as lipid lowering agents.
May 2010, Bioorganic & medicinal chemistry letters,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents.
May 2012, Bioorganic & medicinal chemistry,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
July 2003, Journal of medicinal chemistry,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
April 2014, Bioorganic & medicinal chemistry,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
July 2009, Bioorganic & medicinal chemistry,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Indole-based fibrates as potential hypolipidemic and antiobesity agents.
March 2012, Journal of medicinal chemistry,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
July 2019, European journal of medicinal chemistry,
Koneni V Sashidhara, and Ranga Prasad Dodda, and Ravi Sonkar, and Gopala Reddy Palnati, and Gitika Bhatia
Design, synthesis and biological evaluation of novel indole-piperazine derivatives as antibacterial agents.
June 2023, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!